Ribociclib added to endocrine therapy extends survival in postmenopausal patients with metastatic breast cancer
A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. The results were published today in The New England Journal of Medicine and were first reported at the European Society for...
Caroline Chung, M.D., named MD Anderson’s first Chief Data Officer
The University of Texas MD Anderson Cancer Center today named Caroline Chung, M.D., associate professor of Radiation Oncology and Diagnostic...
MD Anderson and the Rare Cancer Research Foundation launch collaboration to accelerate the development of treatments for rare cancers
The University of Texas MD Anderson Cancer Center and the Rare Cancer Research Foundation today announced the launch of a collaboration designed...
MD Anderson and Siemens Healthineers collaborating to enable consistent clinical implementation of quantitative MRI
The University of Texas MD Anderson Cancer Center and Siemens Healthineers today announced the collaborative development of a global education program focused on enabling the implementation of consistent, high-quality magnetic resonance (MR) imaging in radiation oncology. The program will provide courses for both clinical and administrative groups with the aim of facilitating safe adoption and broader clinical implementation of MR to...
MD Anderson and BostonGene announce strategic alliance to advance personalized cancer diagnostics and treatments
The University of Texas MD Anderson Cancer Center and BostonGene Corporation today announced a strategic alliance to advance the development...
MD Anderson celebrates World Cancer Research Day, progress made to end cancer through research
The University of Texas MD Anderson Cancer Center is proud to support World Cancer Research Day, Sept. 24, and its efforts to promote cancer...
Active Living After Cancer program improves physical functioning of breast cancer survivors
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program, markedly increased their...
MD Anderson Research Highlights for September 22, 2021
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
MD Anderson launches community-led Be Well™ Acres Homes initiative
With the launch of Be Well™ Acres Homes, The University of Texas MD Anderson Cancer Center unites more than 30 organizations, alongside community...
MD Anderson Research Highlights: ESMO 2021 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent studies in basic, translational and...
Link between inflammation and pancreatic cancer development uncovered
HOUSTON ― A new discovery from researchers at The University of Texas MD Anderson Cancer Center has clarified the long-established connection...
MD Anderson to pay tribute to legendary Emil J Freireich, M.D., in virtual celebration on Sept. 23
The University of Texas MD Anderson Cancer Center will celebrate the life of trailblazing oncologist Emil J Freireich, M.D., in a virtual...
Classifying EGFR mutations by structure and function offers better way to match non-small cell lung cancer patients to treatments
Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations...
Long-term benefit of SABR for operable early-stage NSCLC shown in new study
A new study from researchers at The University of Texas MD Anderson Cancer Center showed that stereotactic ablative radiotherapy (SABR) was...
MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics
The University of Texas MD Anderson Cancer Center and SNIPR BIOME today announced a strategic collaboration to advance new CRISPR-based microbiome...
MD Anderson Research Highlights for September 8, 2021
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
MD Anderson and Houston Dynamo FC team up to kick childhood cancer
HOUSTON ― The University of Texas MD Anderson Cancer Center is joining forces with Houston Dynamo FC to raise awareness of childhood cancer...
MD Anderson and Bellicum announce additional license agreement for use of CaspaCIDe® safety switch
The University of Texas MD Anderson Cancer Center and Bellicum Pharmaceuticals, Inc. today announced a global option and license agreement...